Name |
Website |
DPD
patents* |
Comments |
Agilent |
1 |
Fissioned from
Hewlett-Packard; 1 HP patent in DPD |
|
Allergan |
4 |
|
|
Amersham Biosciences |
36 |
formerly Amersham
Pharmacia Biotech |
|
Amgen |
185 |
Acquired Immunex 2001;
patent count includes 90 Immunex patents |
|
Applera |
64 |
incl PE Corp, Perkin
Elmer, Applied Biosystems, PerSeptive Biosystems, and NEN Life Sciences, but
*not* Celera (surveyed separately); formerly PE Corp. |
|
ArQule |
2 |
|
|
Astra-Zeneca |
79 |
|
|
Aventis |
178 |
includes Hoechst,
Marion, Roussel Uclaf, Rhone-Poulenc and Rorer |
|
BASF |
26 |
|
|
Bayer |
55 |
|
|
Beckman Coulter |
29 |
Incl Beckman
Instruments and Coulter |
|
Biogen |
52 |
|
|
Boehringer Ingelheim |
32 |
|
|
Bristol-Myers Squibb |
57 |
Incl 3 DuPont pharma
patents |
|
Chiron |
264 |
Incl 185 Chiron, 76
Cetus and 3 Pathogenesis patents |
|
Corning Life Sciences
(Corning Microarray Technology) |
9 |
Patents held by Ciba
Corning Diagnostics |
|
Genentech |
224 |
Does not include
Hoffmann-La Roche patents (H-LR holds equity in Genentech) |
|
Genzyme |
48 |
Includes 10 patents
from Integrated Genetics |
|
Glaxo SmithKline |
228 |
Includes Glaxo,
Wellcome, Burroughs Wellcome, SmithKline Beecham, Beecham, Smith Kline &
French |
|
Hisamitsu Pharma |
6 |
Formed GenoFunction
subsidiary for genomics |
|
Hitachi Genetic
Systems/MiraiBio, Inc. |
30 |
Subsidiary of Hitachi |
|
Hoffman-La Roche
(Roche Holdings and others) |
131 |
Includes various
Roche, but not Genentech |
|
J&J (Ortho,
Janssen) |
34 |
Includes J&J,
Ortho (various) and Janssen |
|
Lilly |
149 |
|
|
Merck |
131 |
includes
Merck&Co., Merck Patent GmbH, Merck Frosst, Rhone Merieux, and Merck
Sharpe & Dohme |
|
Motorola |
5 |
|
|
Novartis (incl.
Institute of Functional Genomics) |
112 |
includes Sandoz, Ciba,
Geigy and combinations |
|
Novo-Nordisk |
164 |
does *not* include
Zymogenetics (with 80), surveyed separately; de-merger to split pharma and
enzyme Cos. |
|
Otsuka |
13 |
|
|
Pfizer, Inc. (see also
Parke-Davis and Warner-Lambert) |
15 |
Includes
Warner-Lambert and Parke-Davis |
|
Pharmacia & Upjohn |
77 |
includes Pharmacia
pharma, Upjohn and combinations |
|
Qiagen |
6 |
Includes Qiagen
Genomics, a subsidiary |
|
Schering-Plough (incl.
Berlex) |
69 |
includes Berlex |
|
Shimadzu Biotech |
10 |
Subsidiary of Shimadzu
Corp., Japan |
|
Wyeth |
150 |
includes Genetics
Institute and Wyeth-Ayerst; name changed to Wyeth March 2002 |
|
Yamanouchi
Pharmaceutical Co. |
2 |
Announced 50 Billion
yen genomics investment over 5 years, April 2001 (or 12 to 16 percent of
R&D) |
* Patents in the DNA Patent Database (www.genomic.org), which covers DNA-based patents from 1980 through the end of 1999.